Avatar game teaches heart attack patients how to recover

NCT ID NCT07704827

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study tests whether an interactive avatar-based game on a tablet can help people who have had a heart attack learn how to manage their health after leaving the hospital. Participants are randomly assigned to either standard face-to-face discharge education or the tablet game, which covers medications, follow-up care, and warning signs. The game is also available for one month at home. Researchers measure disease knowledge, quality of life, attendance at cardiac rehabilitation, and hospital readmissions over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an avatar-based discharge education application delivered via tablet
What this could lead to
If effective, this game could become a low-cost tool to help heart attack patients better understand their care and stick with cardiac rehabilitation.
What could go wrong
This is a small, early-stage study with 75 participants, so results may not apply to everyone. The game's benefits over standard education may be modest or hard to prove.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Started

Sep 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed ST-elevation or non-ST-elevation myocardial infarction during the current admission or within the preceding three months, including patients readmitted for revascularization (percutaneous coronary intervention or coronary artery bypass grafting) * Planned discharge to home * Able to operate a tablet computer or a smart phone * Provided written informed consent Exclusion Criteria: * Insufficient Turkish-language proficiency to engage with the application or study procedures * Severe comorbidity precluding engagement in lifestyle behaviour change or exercise * Significant cognitive or visual impairment * Concurrent enrolment in another interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac rehabilitation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Suleyman Demirel University

    Isparta, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.